Related Experiment Video
Updated: May 11, 2025
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
MIRO1 mutation leads to metabolic maladaptation resulting in Parkinson's disease-associated dopaminergic neuron loss
Alise Zagare1, Thomas Sauter2, Kyriaki Barmpa1
1Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 2, place de l'Université, L-4365, Esch-sur-Alzette, Luxembourg.
Abstract:
MIRO1 is a mitochondrial outer membrane protein important for mitochondrial distribution, dynamics and bioenergetics. Over the last decade, evidence has pointed to a link between MIRO1 and Parkinson's disease (PD) pathogenesis. Moreover, a heterozygous MIRO1 mutation (p.R272Q) was identified in a PD patient, from which an iPSC-derived midbrain organoid model was derived, showing MIRO1 mutant-dependent selective loss of dopaminergic neurons. Herein, we use patient-specific iPSC-derived midbrain organoids carrying the MIRO1 p.R272Q mutation to further explore the cellular and molecular mechanisms involved in dopaminergic neuron degeneration. Using single-cell RNA sequencing (scRNAseq) analysis and metabolic modeling we show that the MIRO1 p.R272Q mutation affects the dopaminergic neuron developmental path leading to metabolic deficits and disrupted neuron-astrocyte metabolic crosstalk, which might represent an important pathogenic mechanism leading to their loss.
Insights
A Parkinson's disease (PD) mutation in the mitochondrial protein MIRO1 disrupts dopaminergic neuron development. This leads to metabolic deficits and impaired neuron-astrocyte communication, contributing to neurodegeneration.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Mitochondrial Rho GTPase 1 (MIRO1) is crucial for mitochondrial function and distribution.
- MIRO1 dysfunction is implicated in Parkinson's disease (PD) pathogenesis.
- A specific MIRO1 mutation (p.R272Q) was found in a PD patient, linked to dopaminergic neuron loss.
Purpose of the Study:
- To investigate the cellular and molecular mechanisms underlying dopaminergic neuron degeneration caused by the MIRO1 p.R272Q mutation.
- To utilize patient-specific induced pluripotent stem cell (iPSC)-derived midbrain organoids for studying the mutation's effects.
Main Methods:
- Single-cell RNA sequencing (scRNAseq) analysis of iPSC-derived midbrain organoids.
- Metabolic modeling to assess cellular energy production and utilization.
- Analysis of neuron-astrocyte metabolic crosstalk.
Main Results:
- The MIRO1 p.R272Q mutation alters the developmental trajectory of dopaminergic neurons.
- Significant metabolic deficits were observed in affected dopaminergic neurons.
- Disrupted metabolic crosstalk between neurons and astrocytes was identified as a key consequence.
Conclusions:
- The MIRO1 p.R272Q mutation contributes to Parkinson's disease by impairing dopaminergic neuron development and metabolism.
- Metabolic dysfunction and altered neuron-astrocyte interactions are critical pathogenic mechanisms in MIRO1-associated PD.
- Patient-specific iPSC-derived organoids are a valuable model for dissecting PD pathogenesis.
More Related Videos
Related Concept Videos
01:15Parkinson's Disease: Overview
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...